Biopharmaceutical manufacturing and bioprocess development
3 European H2020 organizations list this as part of their work — 2 as their primary capability.
Most active in this area
- INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA
Portuguese biotech institute specializing in bioprocess engineering for vaccines, gene therapies, and biopharmaceutical manufacturing scale-up.
“Central to DiViNe (vaccine downstream processing, their only coordinated project), STACCATO (industrial biopharm manufacturing), TRANSVAC2, CRUZIVAX, BRAV3, PURE (bioseparations), and ARDAT (advanced therapies).”
PrimarySMEPT24 projects - NATIONAL INSTITUTE FOR BIOPROCESSING RESEARCH AND TRAINING LIMITED
Ireland's national institute for biopharmaceutical manufacturing research and workforce training, expanding into gene therapy and advanced biologics production.
“STACCATO (coordinated, EUR 824K) focused on enhancing upstream biopharmaceutical manufacturing, and this is NIBRT's core institutional mission.”
PrimarySMEIE4 projects - TILT BIOTHERAPEUTICS OY
Finnish biotech SME developing oncolytic virus-based cancer immunotherapies with growing biopharmaceutical manufacturing capabilities.
“Participated in STACCATO, an industrial doctorate program for enhancing upstream biopharmaceutical manufacturing processes.”
SMEFI3 projects